Teleflex Incorporated Stock price

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-03-18 pm EDT 5-day change 1st Jan Change
216.5 USD +0.50% Intraday chart for Teleflex Incorporated -4.68% -13.18%
Sales 2024 * 3.09B Sales 2025 * 3.26B Capitalization 10.19B
Net income 2024 * 425M Net income 2025 * 559M EV / Sales 2024 * 3.46 x
Net Debt 2024 * 534M Net cash position 2025 * 34M EV / Sales 2025 * 3.11 x
P/E ratio 2024 *
28.3 x
P/E ratio 2025 *
19.3 x
Employees 14,500
Yield 2024 *
0.66%
Yield 2025 *
0.68%
Free-Float 97.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.50%
1 week-4.68%
Current month-2.84%
1 month-13.78%
3 months-14.52%
6 months+2.46%
Current year-13.18%
More quotes
1 week
213.48
Extreme 213.48
227.78
1 month
213.48
Extreme 213.48
253.06
Current year
213.48
Extreme 213.48
256.85
1 year
177.63
Extreme 177.633
276.43
3 years
177.63
Extreme 177.633
449.38
5 years
177.63
Extreme 177.633
449.38
10 years
99.56
Extreme 99.56
449.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 08-12-31
Director of Finance/CFO 62 11-07-31
Compliance Officer - 17-12-31
Members of the board TitleAgeSince
Director/Board Member 68 17-12-31
Director/Board Member 64 08-12-31
Director/Board Member 69 18-12-31
More insiders
Date Price Change Volume
24-03-18 216.5 +0.50% 225,124
24-03-15 215.4 -1.29% 508,439
24-03-14 218.2 -1.78% 228,612
24-03-13 222.2 -1.94% 196,857
24-03-12 226.6 -0.24% 173,005

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
216.5 USD
Average target price
263.3 USD
Spread / Average Target
+21.62%
Consensus
  1. Stock
  2. Equities
  3. Stock Teleflex Incorporated - Nyse